Showing posts with label chemoresistance. Show all posts
Showing posts with label chemoresistance. Show all posts
Wednesday, August 04, 2010
Targeting annexin A4 to counteract chemoresistance in clear cell carcinoma of the ovary
Take home message: Annexin A4 enhances cancer cell chemoresistance and is overexpressed in tumors of patients with ovarian CCC. Targeting of annexin A4 may represent a future strategy to counteract resistance to chemotherapy in ovarian CCC.
add your opinions
A4
,
chemoresistance
,
chemoresistant
,
clear cell ovarian
,
targeted therapy
Wednesday, June 02, 2010
Functional Proteomic Analysis of Advanced Serous Ovarian Cancer Using Reverse Phase Protein Array: TGF-β Pathway Signaling Indicates Response to Primary chemotherapy
Abstract Purpose: Using reverse phase protein array, we measured protein expression associated with response to primary chemotherapy in patients with advanced-stage, high-grade serous ovarian cancer. Conclusion: TGF-β pathway signaling likely plays an important role as a marker or mediator of chemoresistance in advanced serous ovarian cancer. On this basis, future studies to develop and validate a useful predictor of treatment failure are warranted.
add your opinions
array testing
,
chemoresistance
,
inherited markers
,
protein
,
serous
,
TGF-B
Subscribe to:
Posts
(
Atom
)